23andMe

23andM3 executive ring the Nasdaq opening bell on the day the company goes public
MedTech

23andMine: Anne Wojcicki aims to take genetics company private

23andMe’s co-founder and CEO Anne Wojcicki plans to take the company private after its stock has collapsed by more than 97% since its market debut.
Conor Hale Apr 18, 2024 9:16am
DNA sequence

23andMe lands new label for cholesterol drug response report

Oct 27, 2022 11:12am
23andM3 executive ring the Nasdaq opening bell on the day the company goes public

23andMe snags 3rd FDA nod for genetic cancer risk test

Jan 10, 2022 11:58am
DNA test tube

23andMe to go public in $3.5B deal backed by Virgin

Feb 4, 2021 11:25am
3D medical background with DNA strand

23andMe to lay off 100 as sales turn: CNBC

Jan 24, 2020 10:41am
Emma Walmsley

GSK bets on tech to help boost lagging R&D

Jan 21, 2020 7:25am